2013. ISPOR Annual International Meeting – Patient-Reported Outcomes (PROs) Claims in Products Indicated for Treatment of Non-Small Cell Lung Carcinoma and Approved in Europe and in the United States

Caron M, Emery MP, Acquadro C, Escanez-Virieux MP. Patient-Reported Outcomes (PROs) Claims in Products Indicated for Treatment of Non-Small Cell Lung Carcinoma and Approved in Europe and in the United States. Value Health. 2013 May;16(3):A147. Presented at: ISPOR 18th Annual International Meeting; May 21, 2013; New Orleans, USA.